India rejects Novartis patent appeal

The court says the new polymorph of Glivec does not enhance its efficacy enough to warrant a patent Science Photo Library India's Supreme Court has denied Novartis' appeal against the decision to refuse patent protection for its anticancer drug Glivec .

http://www.rsc.org/chemistryworld/2013/04/india-novartis-glivec-gleevec-patent